[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100377833":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":25,"locations":31,"responsibleParty":49,"collaborators":10,"id":51,"slug":52,"hasResults":53,"nctId":54,"briefTitle":55,"officialTitle":56,"acronym":10,"eligibilityCriteria":57,"healthyVolunteers":58,"sex":59,"minAge":60,"maxAge":10,"enrollmentInfo":61,"targetDuration":10,"studyType":64,"phases":10,"briefSummary":65,"conditions":66,"keywords":10,"overallStatus":34,"whyStopped":10,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"MemorialCare Health System","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Intervention",null,"75g glucose tolerance test to be administered during postpartum hospitalization",[13],"Diagnostic Test: Glucose tolerance test",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DIAGNOSTIC_TEST","Glucose tolerance test","Oral administration of a 75g glucose tolerance test during the postpartum hospitalization",[9],[21],{"name":22,"affiliation":23,"role":24},"Alice Sherman-Brown, MD","Magella Medical Group","PRINCIPAL_INVESTIGATOR",[26],{"name":27,"role":28,"phone":29,"phoneExt":10,"email":30},"Alice Sherman-Bron, MD","CONTACT","(562) 997-8510","alicebrown092@gmail.com",[32],{"facility":33,"status":34,"city":35,"state":36,"zip":37,"country":38,"countryCode":39,"cosmosGeoPoint":40,"geoPoint":45,"contacts":46},"Long Beach Memorial Medical Center\u002FMiller Children's and Women's Hospital","RECRUITING","Long Beach","California","90806","United States","US",{"type":41,"coordinates":42},"Point",[43,44],-118.18923,33.76696,{"lat":44,"lon":43},[47],{"name":22,"role":28,"phone":48,"phoneExt":10,"email":30},"562-997-8510",{"type":50,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100377833","immediate-postpartum-glucose-tolerance-testing-100377833",false,"NCT04199676","Immediate Postpartum Glucose Tolerance Testing","Immediate Postpartum Glucose Tolerance Testing Among Gestational Diabetics: A Comparison to the Gold Standard","Inclusion Criteria:\n\n* Pregnant or recently postpartum (postpartum day 0 or 1)\n* ≥ 18 years of age\n* Gestational age ≥34 weeks\n* A1 or A2 gestational diabetes\n\nExclusion Criteria:\n\n* Medical exclusion from completing glucose tolerance testing\n* Steroid administration within 10 days prior to enrollment\n* Chronic steroid use",true,"FEMALE","18 Years",{"count":62,"type":63},300,"ESTIMATED","OBSERVATIONAL","The objective of this study is to compare the accuracy of a 2hr glucose tolerance test administered during the postpartum hospitalization with the standard of care glucose tolerance testing (administered at 6 weeks postpartum). The primary hypothesis is that the glucose tolerance test administered in the postpartum period will be accurate and will improve compliance with postpartum testing for gestational diabetics.",[67],"Gestational Diabetes","2025-09-02",{"date":70,"type":71},"2025-09-03","ACTUAL",{"date":73,"type":71},"2020-09-01",{"date":75,"type":63},"2026-12-31",{"name":5,"class":6},1]